Werewolf Therapeutics pops more than 30% following IPO (Nasdaq:HOWL)

Early stage anti-cancer biotech Werewolf Therapeutics (HOWL) popped more than 30% shortly after opening Friday on the Nasdaq following its IPO.
Read More